Mount Sinai Health System 技术栈
查看Mount Sinai Health System的技术栈
551
技术
查看Mount Sinai Health System的技术栈
551
技术
Discover the 551 technologies that Mount Sinai Health System uses to build, market and sell its products.
Neuroendocrine and carcinoid tumors are rare forms of cancer. Our world-renowned experts have been treating this rare disease for decades.
Industry | Hospitals and Health Care |
Employees | 42,000 |
HQ Country | United States |
Revenue (USD) | 9,300,000,000 |
Funding (USD) | 36,912,500 |
Last f. round | Nov 11, 2024 |
Founding year | 2013 |
Founding stage | grant |
常见问题
| Technology | Category | Confidence |
|---|---|---|
 ********** | Online Payment Security | high |
 **** ******* | Other Healthcare Tech | high |
 ******* | Customer Satisfaction Ratings | high |
 **** ******* | Other Healthcare Tech | high |
 **** | Project Management | high |
 ********* ********** | Presentation | high |
**** ****** | Other Healthcare Tech | high |
 ****** | Other Healthcare Tech | high |
 ********** | CRM Platforms | high |
 ********* ***** | Office Suites | high |